Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Toxicological Sciences

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/TOXSCI/KFJ022PMID 16237196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changes in secondary glutamate release underlie the developmental regulation of excitotoxic neuronal cell death.

  2005cited by this paper
• Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation.

  2004cited by this paper
• Prostaglandin E2 as a mediator of fever: the role of prostaglandin E (EP) receptors.

  2004cited by this paper
• Vasoconstriction induced by activation of EP1 and EP3 receptors in human lung: effects of ONO-AE-248, ONO-DI-004, ONO-8711 or ONO-8713.

  2004cited by this paper
• Prostanoids, not reactive oxygen species, mediate COX‐2–dependent neurotoxicity

  2004cited by this paper
• Prostaglandin E2 Promotes the Survival of Bone Marrow-Derived Dendritic Cells1

  2004cited by this paper
• Contrasting effects of E type prostaglandin (EP) receptor agonists on core body temperature in rats.

  2003cited by this paper
• Role of Prostaglandin E Receptor EP1 Subtype in the Development of Renal Injury in Genetically Hypertensive Rats

  2003cited by this paper
• Prostanoids in immunity: roles revealed by mice deficient in their receptors.

  2003cited by this paper
• Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase‐2 inhibitor APHS can be reversed by a prostanoid

  2003cited by this paper
• Neuronal overexpression of cyclooxygenase‐2 increases cerebral infarction

  2003cited by this paper
• Expression of inducible nitric oxide synthase and cyclooxygenase‐2 after excitotoxic damage to the immature rat brain

  2002cited by this paper
• Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist.

  2002cited by this paper
• Characterization of EP receptor subtypes responsible for prostaglandin E2‐induced pain responses by use of EP1 and EP3 receptor knockout mice

  2001cited by this paper
• Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice.

  2001cited by this paper
• Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice.

  2000cited by this paper
• Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture.

  2000cited by this paper
• Elevated CSF prostaglandin E2 levels in patients with probable AD.

  2000cited by this paper
• Novel four selective agonists for prostaglandin E receptor subtypes

  1999cited by this paper
• Elevated CSF prostaglandin E2 levels in patients with probable AD.

  1999cited by this paper
• Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.

  1999cited by this paper
• Prostanoid receptors: structures, properties, and functions.

  1999influential reference
• Mechanisms of Reduced Striatal NMDA Excitotoxicity in Type I Nitric Oxide Synthase Knock-Out Mice

  1997cited by this paper
• Cyclooxygenases and the central nervous system.

  1997cited by this paper
• Cyclooxygenase‐2 Induction in Cerebral Cortex: An Intracellular Response to Synaptic Excitation

  1996cited by this paper
• Nitric oxide mediates allodynia induced by intrathecal administration of prostaglandin E2 or prostaglandin F2&agr; in conscious mice

  1995cited by this paper
• Involvement of glutamate receptors in allodynia induced by prostaglandins E2 and F2 alpha injected into conscious mice.

  1994cited by this paper
• Distribution of the messenger RNA for the prostaglandin E receptor subtype EP3 in the mouse nervous system.

  1994cited by this paper
• Involvement of glutamate receptors in allodynia induced by prostaglandins E2 and F2&agr; injected into conscious mice

  1994cited by this paper

• Neuroinflammatory mediators in acquired epilepsy: an update

  2023cites this paper
• Cross-talk between bioactive lipid mediators and the unfolded protein response in ischemic stroke.

  2023cites this paper
• EP1 receptor: Devil in emperors coat

  2023cites this paper
• Arachidonic acid metabolism in health and disease

  2023cites this paper
• Bioactive lipid mediators in the initiation and resolution of inflammation after spinal cord injury.

  2021cites this paper
• Alpha-Synuclein, cyclooxygenase-2 and prostaglandins-EP2 receptors as neuroinflammatory biomarkers of autism spectrum disorders: Use of combined ROC curves to increase their diagnostic values

  2021cites this paper
• Arachidonic Acid Derivatives and Neuroinflammation.

  2021cites this paper
• International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1–4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions

  2020cites this paper
• Prostaglandin E receptors as targets for ischemic stroke: novel evidence and molecular mechanisms of efficacy.

  2020cites this paper
• Effect of Experimental Ischemic Stroke and PGE2 EP1 Selective Antagonism in Alzheimer’s Disease Mouse Models

  2020cites this paper
• Small molecules targeting cyclooxygenase/prostanoid cascade in experimental brain ischemia: Do they translate?

  2020cites this paper
• Neuroinflammation: friend and foe for ischemic stroke

  2019cites this paper
• Bioactive Lipids in Inflammation After Central Nervous System Injury.

  2019cites this paper
• Role of the PGE2 receptor subtypes EP1, EP2, and EP3 in repetitive traumatic brain injury

  2019cites this paper
• Multimodal and Longitudinal Bioimaging Methods for Characterizing the Progressive Course of Dementia

  2019cites this paper
• Isosteviol sodium injection improves outcomes by modulating TLRs/NF-κB-dependent inflammatory responses following experimental traumatic brain injury in rats

  2018cites this paper
• Genetic Deletion of PGF2α-FP Receptor Exacerbates Brain Injury Following Experimental Intracerebral Hemorrhage

  2018cites this paper
• Nous mecanismes implicats en els dèficits transcripcionals i la pèrdua del bdnf en la malaltia de huntington: descripció de noves dianes terapèutiques

  2018cites this paper
• Ischemia‐responsive protein 94 is a key mediator of ischemic neuronal injury‐induced microglial activation

  2017cites this paper
• Prostaglandin E2 Produced by Alginate-Encapsulated Mesenchymal Stromal Cells Modulates the Astrocyte Inflammatory Response.

  2017cites this paper
• Expression of NR1 and apoptosis levels in the hippocampal cells of mice treated with MK‑801.

  2017cites this paper
• EP2 receptor agonist ONO-AE1-259-01 attenuates pentylenetetrazole- and pilocarpine-induced seizures but causes hippocampal neurotoxicity.

  2017cites this paper
• White Matter Tract Integrity in Alzheimer's Disease vs. Late Onset Bipolar Disorder and Its Correlation with Systemic Inflammation and Oxidative Stress Biomarkers

  2017influential citation
• Hippocampal Degeneration after Traumatic Brain Injury : Role of the PGE 2 EP 1 Receptor

  2016cites this paper
• Animal Models of Posttraumatic Seizures and Epilepsy.

  2016cites this paper
• Anti-Inflammatory and Neuroprotective Effects of PGE2 EP4 Signaling in Models of Parkinson’s Disease

  2016cites this paper
• DJ-1 mutation decreases astroglial release of inflammatory mediators.

  2016cites this paper
• 3,4‐methylenedioxymethamphetamine increases excitability in the dentate gyrus: role of 5HT2A receptor‐induced PGE2 signaling

  2016cites this paper
• MDMA Increases Excitability in the Dentate Gyrus: Role of 5HT2A Receptor Induced PGE2 Signaling

  2016cites this paper
• Astrocyte physiopathology: At the crossroads of intercellular networking, inflammation and cell death.

  2015cites this paper
• 3,4-methylenedioxy-methamphetamine(MDMA)-induced increases in hippocampal glutamate concentrations and its impact on the dentate gyrus

  2015cites this paper
• The role of the prostaglandin E2 receptors in vulnerability of oligodendrocyte precursor cells to death

  2015cites this paper
• Toxic role of prostaglandin E2 receptor EP1 after intracerebral hemorrhage in mice.

  2015cites this paper
• Intracerebral hemorrhage outcomes following selective blockade or stimulation of the PGE2 EP1 receptor

  2015cites this paper
• Neuroprotective role of prostaglandin PGE2 EP2 receptor in hemin-mediated toxicity.

  2015cites this paper
• Prostaglandin E2 EP2 Receptor Deletion Attenuates Intracerebral Hemorrhage-Induced Brain Injury and Improves Functional Recovery

  2015cites this paper
• PGE2 Modulates GABAA Receptors via an EP1 Receptor-Mediated Signaling Pathway

  2015cites this paper
• Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke

  2015cites this paper
• Inflammatory Cyclooxygenase Activity and PGE2 Signaling in Models of Alzheimer’s Disease

  2015cites this paper
• Genetic deletion of the prostaglandin E2 E prostanoid receptor subtype 3 improves anatomical and functional outcomes after intracerebral hemorrhage

  2015cites this paper
• PGD2 DP1 receptor stimulation following stroke ameliorates cerebral blood flow and outcomes.

  2014cites this paper
• Neuroprotective role of total oligomeric flavonoids of Cyperus rotundus in rat model of transient focal ischemia

  2014cites this paper
• The prostaglandin EP1 receptor potentiates kainate receptor activation via a protein kinase C pathway and exacerbates status epilepticus.

  2014cites this paper
• Role of the Prostaglandin E2 EP1 Receptor in Traumatic Brain Injury

  2014influential citation
• Inflammation in ischemic stroke: mechanisms, consequences and possible drug targets.

  2014cites this paper
• Prostaglandin E2 Type 1 Receptors Contribute to Neuronal Apoptosis after Transient Forebrain Ischemia

  2013cites this paper
• Contribution of PGE2 EP1 receptor in hemin-induced neurotoxicity

  2013influential citation
• PGE2 EP1 Receptor Deletion Attenuates 6-OHDA-Induced Parkinsonism in Mice: Old Switch, New Target

  2013cites this paper
• Examining the potential of PGE₂ receptor EP₄ as a neuroprotective target following ischaemic injury

  2013cites this paper
• Prostaglandin E2 EP1 Receptor Antagonist Improves Motor Deficits and Rescues Memory Decline in R6/1 Mouse Model of Huntington's Disease

  2013cites this paper
• Role of PGE2 EP1 Receptor in Intracerebral Hemorrhage-Induced Brain Injury

  2013cites this paper
• Neuroprotection mediated by the EP₄ receptor avoids the detrimental side effects of COX-2 inhibitors following ischaemic injury.

  2013cites this paper
• Prostaglandin F2α FP receptor antagonist improves outcomes after experimental traumatic brain injury

  2013cites this paper
• Putative Role of Prostaglandin Receptor in Intracerebral Hemorrhage

  2012cites this paper
• Prostanoid EP1 receptors mediate up‐regulation of the orphan nuclear receptor Nurr1 by cAMP‐independent activation of protein kinase A, CREB and NF‐κB

  2012cites this paper
• Time-dependent effects of treadmill exercise on aversive memory and cyclooxygenase pathway function.

  2012cites this paper
• Role of phospholipase A2s and lipid mediators in secondary damage after spinal cord injury

  2012cites this paper
• PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease.

  2012cites this paper
• Inhibition of prostaglandin E2 EP3 receptors improves stroke injury via anti-inflammatory and anti-apoptotic mechanisms.

  2011cites this paper
• Implications of Gliotransmission for the Pharmacotherapy of CNS Disorders

  2011cites this paper
• Non-Steroidal Anti-Inflammatory Drugs and Cognitive Function: Are Prostaglandins at the Heart of Cognitive Impairment in Dementia and Delirium ?

  2011influential citation
• Roles of prostaglandin E2 in the cochlea.

  2011cites this paper
• Function of prostaglandin E2 EP receptors in the acute outcome of rodent hypoxic ischemic encephalopathy.

  2011cites this paper
• The Mechanisms of Neuroprotection by Melatonin in Cerebral Ischaemia Reperfusion

  2011cites this paper
• Kainic acid-induced neurodegeneration and activation of inflammatory processes in organotypic hippocampal slice cultures: treatment with cyclooxygenase-2 inhibitor does not prevent neuronal death.

  2011cites this paper
• International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress

  2011cites this paper
• Purinergic Signaling Induces Cyclooxygenase-1-Dependent Prostanoid Synthesis in Microglia: Roles in the Outcome of Excitotoxic Brain Injury

  2011cites this paper
• 9 – Cerebral Ischemia and Inflammation

  2011cites this paper
• Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mouse studies.

  2011cites this paper
• Prostaglandin signalling in cerebral ischaemia

  2010cites this paper
• Activation of novel signal transduction pathways by human EP1 prostanoid receptors: The G-protein coupled receptors for prostaglandin E2

  2010cites this paper
• Modulating P‐glycoprotein regulation: Future perspectives for pharmacoresistant epilepsies?

  2010cites this paper
• Cytosolic phospholipase A2 alpha amplifies early cyclooxygenase-2 expression, oxidative stress and MAP kinase phosphorylation after cerebral ischemia in mice

  2010cites this paper
• Roles of the prostaglandin E2 receptors EP subtypes in Alzheimer’s disease

  2010cites this paper
• Microsomal prostaglandin E synthase‐1 and cyclooxygenase‐2 are both required for ischaemic excitotoxicity

  2010cites this paper
• Agents Acting on Prostanoid and Thromboxane Receptors

  2010cites this paper
• The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke

  2010cites this paper
• Roles of the prostaglandin E2 receptors EP subtypes in Alzheimer’s disease

  2010cites this paper
• Acute pathophysiological processes after ischaemic and traumatic brain injury.

  2010cites this paper
• Neuroprotection in a rabbit model of intraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition.

  2010cites this paper
• Microsomal prostaglandin E synthase‐1 contributes to ischaemic excitotoxicity through prostaglandin E2 EP3 receptors

  2010cites this paper
• Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice

  2010cites this paper
• Emerging roles of PGE2 receptors in models of neurological disease.

  2010cites this paper
• Inflammation After Stroke: Mechanisms and Therapeutic Approaches

  2010cites this paper
• Research expression in oligodendrocytes increases sensitivity to excitotoxic death

  2010cites this paper
• Prolonged opportunity for neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity.

  2009cites this paper
• Presynaptic Prostaglandin E2 EP1-Receptor Facilitation of Cerebral Nitrergic Neurogenic Vasodilation

  2009cites this paper
• Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP(1) receptor antagonist for the treatment of inflammatory pain.

  2009cites this paper
• Prostaglandin E2 modulates Na+,K+‐ATPase activity in rat hippocampus: implications for neurological diseases

  2009cites this paper
• PGF2α FP Receptor Contributes to Brain Damage Following Transient Focal Brain Ischemia

  2009cites this paper
• Psychoneuroimmunology of stroke.

  2009cites this paper
• Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia.

  2009cites this paper
• The Neuroprotective Effect of Prostaglandin E2 EP1 Receptor Inhibition has a Wide Therapeutic Window, is Sustained in Time and is not Sexually Dimorphic

  2009cites this paper
• Therapeutic targets in prostaglandin E2 signaling for neurologic disease.

  2008cites this paper
• Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controls.

  2008cites this paper
• Synthesis and Pharmacological Properties of Fluorinated Prostanoids

  2008cites this paper
• Modulation of pentylenetetrazol-induced seizures by prostaglandin E2 receptors.

  2008cites this paper
• Prostanoids, Diabetes and the Brain

  2008cites this paper
• Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation

  2008influential citation
• Prostacyclin receptor deletion aggravates hippocampal neuronal loss after bilateral common carotid artery occlusion in mouse.

  2008cites this paper